Novartis is reimagining collaboration by offering unique partnership opportunities within the UK health and care systems. Here you can explore our library of Joint Working Project (JWP) case studies and discover how Novartis has been working in partnership with the NHS to deliver optimised care across the UK.

Learn more about the different partnerships with Novartis and the NHS across the UK and how these projects have focused on providing access to solutions with the aim of transforming patient care. Click the hotspots on the map below to find out more about the JWP case studies in that area:

 

Click below for more information on some of the partnerships between Novartis and the NHS, and how these have changed the way the healthcare system operates, tackling inequalities and improving patient outcomes and experience.

 

Preview image. Presentation on Penguin patient management system video.

Cievert Limited Penguin patient management system

Learn more about how Novartis are partnering with NHS organisations through Joint Working to introduce this software solution from Cievert Ltd to support patient care.

See more

Preview image Delivering and improving care for people with cancer leaflet.

Delivering and improving care for people with cancer

Discover the partnership between Novartis and the NHS creating a new vision for world-leading cancer care. This leaflet provides you with a compilation of Novartis’ collaborations aligned to national cancer strategies.

Download

CCG, clinical commissioning group; CNS, clinical nurse specialist; EIBPS, Early Inflammatory Back Pain Service; GCC, Guy’s Cancer Centre; GGC, Greater Glasgow & Clyde; GM, Greater Manchester; HF, heart failure; JWP, joint working project; MDT, multidisciplinary team; MPN, myeloproliferative neoplasm; MS, multiple sclerosis; NET, neuro-endocrine tumour; NHS, National Health Service; SACT, systemic anti-cancer therapy; sBC, secondary breast cancer; UCLH, University College London Hospital.

Rate this content: 
Average: 4.4 (8 votes)
UK | May 2023 | 282633

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]